Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
Effective treatment of tuberculosis (TB) remains a serious public health problem in many countries, including Brazil, especially when considering drug-resistant disease. Xpert MTB/RIF has been implemented in many countries to reduce the time to TB diagnosis and to rapidly detect rifampicin resistanc...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2019-08-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/5/3/00043-2019.full |
id |
doaj-8d19b6e08ae54f24a0051932aab9c3cc |
---|---|
record_format |
Article |
spelling |
doaj-8d19b6e08ae54f24a0051932aab9c3cc2020-11-25T02:33:13ZengEuropean Respiratory SocietyERJ Open Research2312-05412019-08-015310.1183/23120541.00043-201900043-2019Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern BrazilCinara Silva Feliciano0Lucas José Bazzo Menon1Livia Maria Pala Anselmo2Anzaan Dippenaar3Robin Mark Warren4Wilson Araújo Silva5Valdes Roberto Bollela6 Dept of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), São Paulo, Brazil Dept of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), São Paulo, Brazil Dept of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), São Paulo, Brazil DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa Center for Medical Genomics, Clinics Hospital at Ribeirão Preto Medical School, FMRP-USP, São Paulo, Brazil Dept of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), São Paulo, Brazil Effective treatment of tuberculosis (TB) remains a serious public health problem in many countries, including Brazil, especially when considering drug-resistant disease. Xpert MTB/RIF has been implemented in many countries to reduce the time to TB diagnosis and to rapidly detect rifampicin resistance. The study aimed to describe and evaluate Xpert MTB/RIF performance in diagnosing pulmonary TB and rifampicin resistance in a tertiary healthcare facility in Brazil. A cross-sectional study was performed, which included all isolates of confirmed pulmonary TB patients from 2015 to 2018. Both Xpert MTB/RIF and GenoType MTBDRplus assays were performed to detect rifampicin and isoniazid resistance. In addition, isolates with detected resistance to rifampicin and/or isoniazid were analysed by phenotypic testing using MGIT-960 SIRE kit and whole-genome sequencing (WGS) using Illumina MiSeq Sequencing System. 2148 respiratory specimens tested with Xpert MTB/RIF were included: n=1556 sputum, n=348 bronchoalveolar lavage and n=244 gastric washing. The overall Xpert MTB/RIF sensitivity in sputum was 94% and the overall specificity was 98%. The negative predictive value in sputum of all the patients was 99% with a positive predictive value of 89%. The concordance between Xpert MTB/RIF and phenotypic susceptibility test was 94.1%, while its concordance with WGS was 78.9%. Xpert MTB/RIF is a rapid and accurate diagnostic strategy for pulmonary TB, which can contribute to improvement in TB control. However, detection of rifampicin resistance might be associated with false-positive results.http://openres.ersjournals.com/content/5/3/00043-2019.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cinara Silva Feliciano Lucas José Bazzo Menon Livia Maria Pala Anselmo Anzaan Dippenaar Robin Mark Warren Wilson Araújo Silva Valdes Roberto Bollela |
spellingShingle |
Cinara Silva Feliciano Lucas José Bazzo Menon Livia Maria Pala Anselmo Anzaan Dippenaar Robin Mark Warren Wilson Araújo Silva Valdes Roberto Bollela Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil ERJ Open Research |
author_facet |
Cinara Silva Feliciano Lucas José Bazzo Menon Livia Maria Pala Anselmo Anzaan Dippenaar Robin Mark Warren Wilson Araújo Silva Valdes Roberto Bollela |
author_sort |
Cinara Silva Feliciano |
title |
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil |
title_short |
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil |
title_full |
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil |
title_fullStr |
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil |
title_full_unstemmed |
Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil |
title_sort |
xpert mtb/rif performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern brazil |
publisher |
European Respiratory Society |
series |
ERJ Open Research |
issn |
2312-0541 |
publishDate |
2019-08-01 |
description |
Effective treatment of tuberculosis (TB) remains a serious public health problem in many countries, including Brazil, especially when considering drug-resistant disease. Xpert MTB/RIF has been implemented in many countries to reduce the time to TB diagnosis and to rapidly detect rifampicin resistance. The study aimed to describe and evaluate Xpert MTB/RIF performance in diagnosing pulmonary TB and rifampicin resistance in a tertiary healthcare facility in Brazil. A cross-sectional study was performed, which included all isolates of confirmed pulmonary TB patients from 2015 to 2018. Both Xpert MTB/RIF and GenoType MTBDRplus assays were performed to detect rifampicin and isoniazid resistance. In addition, isolates with detected resistance to rifampicin and/or isoniazid were analysed by phenotypic testing using MGIT-960 SIRE kit and whole-genome sequencing (WGS) using Illumina MiSeq Sequencing System. 2148 respiratory specimens tested with Xpert MTB/RIF were included: n=1556 sputum, n=348 bronchoalveolar lavage and n=244 gastric washing. The overall Xpert MTB/RIF sensitivity in sputum was 94% and the overall specificity was 98%. The negative predictive value in sputum of all the patients was 99% with a positive predictive value of 89%. The concordance between Xpert MTB/RIF and phenotypic susceptibility test was 94.1%, while its concordance with WGS was 78.9%. Xpert MTB/RIF is a rapid and accurate diagnostic strategy for pulmonary TB, which can contribute to improvement in TB control. However, detection of rifampicin resistance might be associated with false-positive results. |
url |
http://openres.ersjournals.com/content/5/3/00043-2019.full |
work_keys_str_mv |
AT cinarasilvafeliciano xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil AT lucasjosebazzomenon xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil AT liviamariapalaanselmo xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil AT anzaandippenaar xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil AT robinmarkwarren xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil AT wilsonaraujosilva xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil AT valdesrobertobollela xpertmtbrifperformancetodiagnosetuberculosisandrifampicinresistanceinareferencecentreinsouthernbrazil |
_version_ |
1724815606292676608 |